Literature DB >> 3284977

Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation.

J D Rowley1.   

Abstract

The 14;18 translocation [t(14;18)] is the most common chromosome abnormality noted in the non-Hodgkin's lymphomas (NHL). Although the translocation is seen in various histologic subtypes, it is most commonly associated with the follicular lymphomas, especially the small-cleaved cell (FSC) and mixed-cell (FM) subtypes. The translocation breakpoint has been cloned and DNA probes from the junction on chromosome 18 can now be used to detect the genetic consequences of the translocation in tumors with few dividing cells. This will allow a more precise classification of this subset of lymphomas and should lead to better understanding of the biology of this category of lymphomas. Finally, these insights will help in the development of more effective and possibly less toxic therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284977     DOI: 10.1200/JCO.1988.6.5.919

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  18 in total

1.  Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.

Authors:  Kojo S J Elenitoba-Johnson; Stephen D Jenson; Robert T Abbott; Robert A Palais; Sandra D Bohling; Zhaosheng Lin; Sheryl Tripp; Paul J Shami; Lai Y Wang; Robert W Coupland; Rena Buckstein; Bayardo Perez-Ordonez; Sherrie L Perkins; Ian D Dube; Megan S Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

Review 2.  [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].

Authors:  S Hartmann; S Cogliatti; M-L Hansmann
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

3.  Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.

Authors:  H Ohno; T Furukawa; S Fukuhara; S Q Zong; H Kamesaki; T B Shows; M M Le Beau; T W McKeithan; T Kawakami; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Synchronous indolent primary gastrointestinal lymphomas managed successfully with conservative measures.

Authors:  Andrew S Brohl; Joo Y Song; Ron Lieberman; Barry Gause
Journal:  Am J Ther       Date:  2013 Sep-Oct       Impact factor: 2.688

5.  Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Authors:  H Nowotny; H Karlic; H Grüner; J Hirsch; M Vesely; A Nader; R Heinz
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

6.  Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.

Authors:  Naoto Tomita; Mami Tokunaka; Naoya Nakamura; Kengo Takeuchi; Junki Koike; Shigeki Motomura; Ko Miyamoto; Ako Kikuchi; Rie Hyo; Yoshihiro Yakushijin; Yasufumi Masaki; Soichiro Fujii; Takamasa Hayashi; Yoshiaki Ishigatsubo; Ikuo Miura
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

7.  Lack of Bcl-2 expression in feline follicular lymphomas.

Authors:  Manfred Henrich; Anna Bauknecht; Werner Hecht; Manfred Reinacher
Journal:  J Vet Diagn Invest       Date:  2019-10-04       Impact factor: 1.279

8.  Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas.

Authors:  Gaia Goteri; Guendalina Lucarini; Antonio Zizzi; Antonello Costagliola; Federica Giantomassi; Daniela Stramazzotti; Corrado Rubini; Pietro Leoni
Journal:  Diagn Pathol       Date:  2011-10-11       Impact factor: 2.644

9.  Translocation t(14;18) in B cell lymphomas as a cause for defective immunoglobulin production.

Authors:  D de Jong; B M Voetdijk; G J Van Ommen; J C Kluin-Nelemans; G C Beverstock; P M Kluin
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Lymphomas with testicular localisation show a consistent BCL-2 expression without a translocation (14;18): a molecular and immunohistochemical study.

Authors:  A C Lambrechts; L H Looijenga; M B van't Veer; J van Echten; W Timens; J W Oosterhuis
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.